Abstract
Whole transcriptome sequencing (RNA-Seq) has gained prominence for the detection of fusions in solid tumors. Here, we describe the development and validation of an in-house RNA-Seq-based test system (FusionSeq™ 2.0) for the detection of clinically actionable gene fusions, in formalin-fixed paraffin-embedded (FFPE) specimens, using seventy tumor samples with varying fusion status. Conditions were optimized for RNA input of 50 ng, shown to be adequate to call known fusions at as low as 20% neoplastic content. Evaluation of assay performance between FFPE and fresh-frozen (FF) tissues exhibited little to no difference in fusion calling capability. Performance analysis of the assay validation data determined 100% accuracy, sensitivity, specificity, and reproducibility. This clinically developed and validated RNA-Seq-based approach for fusion detection in FPPE samples was shown to be on par if not superior to off-the-shelf commercially offered assays. With gene fusions implicated in a variety of cancer types, offering high-quality, low-cost molecular testing services for FFPE specimens will serve to best benefit the patient and the advancement of precision medicine in molecular oncology.
Key messages
A custom RNA-Seq-based test system (FusionSeq™ 2.0) for the detection of clinically actionable gene fusions,
-
Evaluation of assay performance between FFPE and fresh-frozen (FF) tissues exhibited little to no difference in fusion calling capability.
-
The assay can be performed with low RNA input and neoplastic content.
-
Performance characteristics of the assay validation data determined 100% accuracy, sensitivity, specificity, and reproducibility.
Similar content being viewed by others
Availability of data and materials (data transparency)
All data generated or analyzed during this study are included in this published article (and its supplementary information files).
References
Gasparini P, Sozzi G, Pierotti MA (2007) The role of chromosomal alterations in human cancer development. J Cell Biochem 102:320–331. https://doi.org/10.1002/jcb.21481
Mitelman F, Johansson B, Mertens F (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7:233–245. https://doi.org/10.1038/nrc2091
Osborne C, Wilson P, Tripathy D (2004) Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist 9:361–377
Faderl S, Talpaz M, Estrov Z, O’Brien S, Kurzrock R, Kantarjian HM (1999) The biology of chronic myeloid leukemia. N Engl J Med 341:164–172. https://doi.org/10.1056/NEJM199907153410306
Grunewald TG, Bernard V, Gilardi-Hebenstreit P, Raynal V, Surdez D, Aynaud MM, Mirabeau O, Cidre-Aranaz F, Tirode F, Zaidi S et al (2015) Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite. Nat Genet 47:1073–1078. https://doi.org/10.1038/ng.3363
Sasaki T, Rodig SJ, Chirieac LR, Janne PA (2010) The biology and treatment of EML4-ALK non-small cell lung cancer. Eur J Cancer 46:1773–1780. https://doi.org/10.1016/j.ejca.2010.04.002
Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, Cao Q, Prensner JR, Rubin MA, Shah RB et al (2008) Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10:177–188
Dupain C, Harttrampf AC, Boursin Y, Lebeurrier M, Rondof W, Robert-Siegwald G, Khoueiry P, Geoerger B, Massaad-Massade L (2019) Discovery of new fusion transcripts in a cohort of pediatric solid cancers at relapse and relevance for personalized medicine. Mol Ther 27:200–218. https://doi.org/10.1016/j.ymthe.2018.10.022
Pophali PA, Patnaik MM (2016) The role of new tyrosine kinase inhibitors in chronic myeloid leukemia. Cancer J 22:40–50. https://doi.org/10.1097/PPO.0000000000000165
Kearney L (2001) Molecular cytogenetics. Best Pract Res Clin Haematol 14:645–669. https://doi.org/10.1053/beha.2001.0159
Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, Gray J (1988) Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci USA 85:9138–9142
Rowley JD (1973) Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290–293
Lejeune J, Gautier M, Turpin R (1959) Study of somatic chromosomes from 9 mongoloid children. C R Hebd Seances Acad Sci 248:1721–1722
Duncavage EJ, Abel HJ, Szankasi P, Kelley TW, Pfeifer JD (2012) Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia. Mod Pathol 25:795–804. https://doi.org/10.1038/modpathol.2012.29
Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M, Curran JA, Balasubramanian S, Bloom T, Brennan KW et al (2012) Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 18:382–384. https://doi.org/10.1038/nm.2673
Benayed R, Offin M, Mullaney K, Sukhadia P, Rios K, Desmeules P, Ptashkin R, Won H, Chang J, Halpenny D et al (2019) High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden. Clin Cancer Res 25:4712–4722. https://doi.org/10.1158/1078-0432.CCR-19-0225
Kim J, Kim S, Ko S, In YH, Moon HG, Ahn SK, Kim MK, Lee M, Hwang JH, Ju YS et al (2015) Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples. Genes Chromosomes Cancer 54:681–691. https://doi.org/10.1002/gcc.22279
Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM (2009) Transcriptome sequencing to detect gene fusions in cancer. Nature 458:97–101. https://doi.org/10.1038/nature07638
Zhang J, White NM, Schmidt HK, Fulton RS, Tomlinson C, Warren WC, Wilson RK, Maher CA (2016) INTEGRATE: gene fusion discovery using whole genome and transcriptome data. Genome Res 26:108–118. https://doi.org/10.1101/gr.186114.114
Levin JZ, Berger MF, Adiconis X, Rogov P, Melnikov A, Fennell T, Nusbaum C, Garraway LA, Gnirke A (2009) Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome Biol 10:R115. https://doi.org/10.1186/gb-2009-10-10-r115
Haas BJ, Dobin A, Li B, Stransky N, Pochet N, Regev A (2019) Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol 20:213. https://doi.org/10.1186/s13059-019-1842-9
Esteve-Codina A, Arpi O, Martinez-Garcia M, Pineda E, Mallo M, Gut M, Carrato C, Rovira A, Lopez R, Tortosa A et al (2017) A comparison of RNA-Seq results from paired formalin-fixed paraffin-embedded and fresh-frozen glioblastoma tissue samples. PLoS ONE 12:e0170632. https://doi.org/10.1371/journal.pone.0170632
Mittempergher L, de Ronde JJ, Nieuwland M, Kerkhoven RM, Simon I, Rutgers EJ, Wessels LF, Van’t Veer LJ (2011) Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue. PLoS ONE 6:e17163. https://doi.org/10.1371/journal.pone.0017163
Selvam P, Kelly K, Hesse AN, Spitzer D, Reddi HV (2019) Evaluating gene fusions in solid tumors - clinical experience using an RNA based 53 gene next-generation sequencing panel. Cancer Genet 233:32–42. https://doi.org/10.1016/j.cancergen.2019.03.001
Morikawa K, Walker SM, Jessup JM, Fidler IJ (1988) In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 48:1943–1948
Nicorici D, Şatalan M, Edgren H, Kangaspeska S, Murumägi A, Kallioniemi O, Virtanen S, Kilkku O (2014) FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data. bioRxiv 011650. https://doi.org/10.1101/011650
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. https://doi.org/10.1093/bioinformatics/bts635
Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. https://doi.org/10.1186/gb-2009-10-3-r25
Langmead B, Salzberg SL (2012) Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. https://doi.org/10.1038/nmeth.1923
Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA et al (2015) A global reference for human genetic variation. Nature 526:68–74. https://doi.org/10.1038/nature15393
Lee M, Lee K, Yu N, Jang I, Choi I, Kim P, Jang YE, Kim B, Kim S, Lee B et al (2017) ChimerDB 3.0: an enhanced database for fusion genes from cancer transcriptome and literature data mining. Nucleic Acids Res 45:D784–D789. https://doi.org/10.1093/nar/gkw1083
Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A et al (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 19:4–23. https://doi.org/10.1016/j.jmoldx.2016.10.002
Reeser JW, Martin D, Miya J, Kautto EA, Lyon E, Zhu E, Wing MR, Smith A, Reeder M, Samorodnitsky E et al (2017) Validation of a targeted RNA sequencing assay for kinase fusion detection in solid tumors. J Mol Diagn 19:682–696. https://doi.org/10.1016/j.jmoldx.2017.05.006
Wimmer I, Troscher AR, Brunner F, Rubino SJ, Bien CG, Weiner HL, Lassmann H, Bauer J (2018) Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh fresh frozen and formalin-fixed paraffin-embedded tissue samples. Sci Rep 8:6351. https://doi.org/10.1038/s41598-018-24781-6
Winters JL, Davila JI, McDonald AM, Nair AA, Fadra N, Wehrs RN, Thomas BC, Balcom JR, Jin L, Wu X et al (2018) Development and verification of an RNA sequencing (RNA-Seq) assay for the detection of gene fusions in tumors. J Mol Diagn 20:495–511. https://doi.org/10.1016/j.jmoldx.2018.03.007
Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F et al (2013) The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet 45:1141–1149. https://doi.org/10.1038/ng.2734
Zhong XY, Holzgreve W, Huang DJ (2008) Isolation of cell-free RNA from maternal plasma. Methods Mol Biol 444:269–273. https://doi.org/10.1007/978-1-59745-066-9_21
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Daniel Bergeron, Harshpreet Chandok, Qian Nie, and Honey V Reddi. The first draft of the manuscript was written by Daniel Bergeron, Harshpreet Chandok, Qian Nie, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable. All human specimens used in this study were obtained from commercial sources as listed in the material and methods section of this manuscript. As such no informed consent or waiver for participation was required. DNA/RNA from PDX animals was obtained from the PDX core. The lab was not involved in the care of animals.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bergeron, D., Chandok, H., Nie, Q. et al. RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq™ 2.0 assay. J Mol Med 100, 323–335 (2022). https://doi.org/10.1007/s00109-021-02149-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-021-02149-0